NO964022L - -2-antichymotrypsinanaloger med elastasehemmende aktivitet - Google Patents

-2-antichymotrypsinanaloger med elastasehemmende aktivitet

Info

Publication number
NO964022L
NO964022L NO964022A NO964022A NO964022L NO 964022 L NO964022 L NO 964022L NO 964022 A NO964022 A NO 964022A NO 964022 A NO964022 A NO 964022A NO 964022 L NO964022 L NO 964022L
Authority
NO
Norway
Prior art keywords
antichymotrypsin
analogs
inhibitory activity
elastase inhibitory
present
Prior art date
Application number
NO964022A
Other languages
English (en)
Other versions
NO964022D0 (no
Inventor
Barry Cooperman
Harvey Rubin
Norman Schechter
Zhi Mei Wang
Original Assignee
Trustees Of The Untiversity Of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trustees Of The Untiversity Of filed Critical Trustees Of The Untiversity Of
Publication of NO964022L publication Critical patent/NO964022L/no
Publication of NO964022D0 publication Critical patent/NO964022D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Foreliggende oppfinnelse skaffer tilvele en analog av human a-1-antichymotrypsin der aminosyren l posisjon 358 blir valgt fra gruppen bestående av metionln, l Isoleucln, valln, alanin, asparaginsyre, treonin og glutaminsyre. a-1-antichymotrypsinanalogene l oppfln- : nelsen er effektive hemmere av human neutrofil elastase. Foreliggende oppfinnelse tllvelebrlnger også nuklelnsyresekvenser som koder for disse analogene, ekspresjonsvektorer, transformerte vertsceller, og en fremgangsmåte for å fremstille analogene.
NO964022A 1994-03-31 1996-09-24 -2-antichymotrypsinanaloger med elastasehemmende aktivitet NO964022D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/221,078 US5674708A (en) 1989-06-23 1994-03-31 α-1-antichymotrypsin analogues having elastase inhibitory activity
PCT/US1994/004735 WO1995027055A1 (en) 1994-03-31 1994-04-29 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY

Publications (2)

Publication Number Publication Date
NO964022L true NO964022L (no) 1996-09-24
NO964022D0 NO964022D0 (no) 1996-09-24

Family

ID=22826247

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964022A NO964022D0 (no) 1994-03-31 1996-09-24 -2-antichymotrypsinanaloger med elastasehemmende aktivitet

Country Status (17)

Country Link
US (1) US5674708A (no)
EP (1) EP0754228A4 (no)
JP (1) JPH09512423A (no)
CN (1) CN1145637A (no)
AU (1) AU696995B2 (no)
BG (1) BG100939A (no)
CA (1) CA2186908A1 (no)
CZ (1) CZ281796A3 (no)
FI (1) FI963891A (no)
HU (1) HUT74901A (no)
LV (1) LV11747B (no)
NO (1) NO964022D0 (no)
NZ (1) NZ269619A (no)
PL (1) PL316433A1 (no)
SI (1) SI9420082A (no)
SK (1) SK138196A3 (no)
WO (1) WO1995027055A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827662A (en) * 1989-06-23 1998-10-27 The Trustees Of The University Of Pennsylvania Methods for detecting genetic mutations resulting in protease inhibitor insufficiencies
US5723316A (en) * 1989-06-23 1998-03-03 Trustees Of The University Of Pennsylvania α-1-antichymotrypsin analogues having chymase inhibiting activity
US6458777B1 (en) 1998-03-13 2002-10-01 Mucosal Therapeutics Llc Methods and compositions for treating and preventing mucositis
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
KR20030046469A (ko) * 2000-09-29 2003-06-12 오노 야꾸힝 고교 가부시키가이샤 염증성 장질환 치료제
WO2002088180A2 (en) * 2001-04-30 2002-11-07 Switch Biotech Ag Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
DE10121255A1 (de) 2001-04-30 2002-11-07 Switch Biotech Ag Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
EP1415664A1 (en) * 2002-10-30 2004-05-06 Switch Biotech Aktiengesellschaft Use of alpha 1-antichymotrypsin in combination with alpha-1-antitrypsin for treating/preventing diabetes associated or poorly healing arterial wounds
AU2006297036A1 (en) * 2005-09-29 2007-04-05 University Of Alberta Compositions for and methods of granzyme B inhibition
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
US20220265787A1 (en) * 2019-07-31 2022-08-25 StemRIM Inc. Composition for promoting growth or suppressing decrease of mesenchymal stem cells
US20210051956A1 (en) * 2019-08-23 2021-02-25 The Hong Kong University Of Science And Technology Elasnin, a bacteriostatic agent that has potent antibiofilm activities against both mono- and multi-species biofilm
JP2023500182A (ja) 2019-09-17 2023-01-05 メレオ バイオファーマ ４ リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
EP4106757B1 (en) 2020-04-16 2023-08-23 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
TW202325294A (zh) 2021-10-20 2023-07-01 英商梅瑞奧生物製藥４有限公司 用於治療纖維化之嗜中性球彈性蛋白酶抑制劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732973A (en) * 1984-06-14 1988-03-22 Chiron Corporation Active site modified protease α-1-antitrypsin inhibitors
US5008242A (en) * 1986-12-24 1991-04-16 John Lezdey Treatment of inflammation using 1-antichymotrypsin
US4916117A (en) * 1986-12-24 1990-04-10 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin
US5723316A (en) * 1989-06-23 1998-03-03 Trustees Of The University Of Pennsylvania α-1-antichymotrypsin analogues having chymase inhibiting activity
US5266465A (en) * 1989-06-23 1993-11-30 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5252725A (en) * 1989-06-23 1993-10-12 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5079336A (en) * 1989-06-23 1992-01-07 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production

Also Published As

Publication number Publication date
SK138196A3 (en) 1997-07-09
HU9602674D0 (en) 1996-11-28
EP0754228A1 (en) 1997-01-22
CZ281796A3 (en) 1997-05-14
US5674708A (en) 1997-10-07
SI9420082A (en) 1997-06-30
AU7393694A (en) 1995-10-23
CA2186908A1 (en) 1995-10-12
NZ269619A (en) 1998-01-26
LV11747A (lv) 1997-04-20
JPH09512423A (ja) 1997-12-16
EP0754228A4 (en) 1997-12-10
WO1995027055A1 (en) 1995-10-12
FI963891A0 (fi) 1996-09-27
PL316433A1 (en) 1997-01-06
LV11747B (en) 1997-10-20
HUT74901A (en) 1997-02-28
FI963891A (fi) 1996-09-27
AU696995B2 (en) 1998-09-24
CN1145637A (zh) 1997-03-19
NO964022D0 (no) 1996-09-24
BG100939A (en) 1997-10-31

Similar Documents

Publication Publication Date Title
NO964022L (no) -2-antichymotrypsinanaloger med elastasehemmende aktivitet
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
PT737207E (pt) Inibidores de plasmina humana derivados de dominios kunitz
ES2150983T3 (es) Productos proteicos bactericidas estables que incrementan la permeabilidad y composiciones farmaceuticas que los contienen.
DK520284D0 (da) Enzyminhibering
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
DE3687763D1 (de) Oxidationsbestaendige il-2-muteine und ihre herstellung, diese muteine enthaltende zusammensetzungen, solche muteine kodierende dns-sequenzen und expressionsvektoren und korrespondierende transformierte wirtzellen.
DK0495918T3 (da) Aminosyre-beta-lyaseenzyminhibitorer som deodoranter
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
NO971621D0 (no) Keratinocyttvekstfaktoranaloger
ATE121754T1 (de) Vakzine gegen bordetella.
DE68917837D1 (de) Peptid-Verbindungen.
FI892185A (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi
ATE228164T1 (de) Chemotaktische faktoren
EP0312157A3 (en) Tetrapeptide renin inhibitors having a novel c-terminal amino acid
ATE107666T1 (de) Amblyommin, ein neuer wirkstoff für die antikoagulationstherapie.
ATE124955T1 (de) Substrat-peptide.
ATE82984T1 (de) Hemmende peptide.
DE69526087D1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
DK0469523T3 (da) Kloning og overekspression af glucose-6-phosphatdehydrogenase fra Leuconostoc dextranicus
KR880701073A (ko) 제조합 dna 기법에 의해 생성된 민악티빈
IT1237490B (it) Procedimento per la sintesi della 1 n (s delta ammino alfa idrossibutirril)kamanycin a basato sul trattamento della 1 n (s delta benzilossicarbonilammino alfa idrossibutirril) 3,6' di n benzilossicarbonilkanamycin a con acido formico
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
FI972605A0 (fi) Myrsyraloesning med saenkt korroderande verkan

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application